VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal Cancer
Phase 2 Completed
75 enrolled 15 charts
Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver
Phase 2 Completed
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
Phase 2 Completed
10 enrolled 14 charts
Akt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
Phase 2 Completed
18 enrolled 7 charts
BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
Phase 2 Completed
51 enrolled 11 charts
Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases
Phase 2 Withdrawn
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
Phase 2 Completed
79 enrolled 12 charts
Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Withdrawn
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia
Phase 2 Completed
85 enrolled 10 charts
Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy
Phase 2 Terminated
1 enrolled 5 charts
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy
Phase 2 Completed
188 enrolled 11 charts
Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 2 Terminated
39 enrolled 9 charts
Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
Phase 2 Completed
66 enrolled 7 charts
Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 2 Completed
30 enrolled
Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer
Phase 2 Completed
70 enrolled
SB-715992 in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Completed
64 enrolled 7 charts
Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma
Phase 2 Completed
45 enrolled 18 charts
Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Completed
47 enrolled 6 charts
Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Unknown
20 enrolled
Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
Phase 2 Unknown
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
Phase 2 Unknown
225 enrolled
Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Unknown
46 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery
Phase 2 Unknown
40 enrolled
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Unknown
51 enrolled
Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
Phase 2 Completed
75 enrolled
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
Phase 2 Completed
40 enrolled
Antineoplaston Therapy in Treating Patients With Colon Cancer
Phase 2 Withdrawn
Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 2 Completed
Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
Phase 2 Completed
Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
Phase 2 Completed
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer
Phase 2 Completed
Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer
Phase 2 Completed
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Phase 2 Completed
Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy
Phase 2 Completed
Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
Phase 2 Completed
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Phase 2 Completed
180 enrolled
SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
Phase 2 Terminated
37 enrolled
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
Phase 2 Completed
Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
Phase 2 Terminated
26 enrolled
Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
Phase 2 Completed
37 enrolled
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
Phase 2 Completed
32 enrolled
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan
Phase 2 Completed
40 enrolled
Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer
Phase 2 Completed
Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer
Phase 2 Terminated
80 enrolled
Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer
Phase 2 Completed
37 enrolled
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer
Phase 2 Terminated
50 enrolled
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver
Phase 2 Completed
8 enrolled
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
Phase 2 Completed
67 enrolled